HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.

about

HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.

Item

http://www.wikidata.org/entity/Q47639413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@en

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@nl

type

Item

label

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@en

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@nl

prefLabel

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@en

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@nl

P1476

HLA-Mismatched Microtransplant ...... ransplantation Interest Group.

@en

P2093

Ann Mohrbacher

http://www.w3.org/2001/XMLSchema#string

Anthony D Sung

http://www.w3.org/2001/XMLSchema#string

Bo Cai

http://www.w3.org/2001/XMLSchema#string

Bo Yao

http://www.w3.org/2001/XMLSchema#string

Chang-Lin Yu

http://www.w3.org/2001/XMLSchema#string

David A Rizzieri

http://www.w3.org/2001/XMLSchema#string

De-Pei Wu

http://www.w3.org/2001/XMLSchema#string

Elizabeth F Krakow

http://www.w3.org/2001/XMLSchema#string

Hong-Li Zuo

http://www.w3.org/2001/XMLSchema#string

Hong-Xia Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Age and acute myeloid leukemia.

High-dose daunorubicin in older patients with acute myeloid leukemia.

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.

A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.

P304

54-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAONCOL.2017.2656

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28910431

http://www.w3.org/2001/XMLSchema#string

P932

5833633

http://www.w3.org/2001/XMLSchema#string